Covington & Burling LLP has advised AbbVie, and Ropes & Gray LLP have advised Gilgamesh Pharmaceuticals. AbbVie has entered into a definitive agreement to acquire the...
AbbVie Acquires Gilgamesh’s Lead Antidepressant Program for Up to $1.2 Billion
Gilgamesh Pharmaceuticals’ Collaboration with AbbVie
Ropes & Gray represented Gilgamesh Pharmaceuticals in a transaction. Gilgamesh Pharmaceuticals announced it has entered into a collaboration and option-to-license agreement with AbbVie (NYSE: ABBV) to...